AI-extracted claim
“The first patient in the Paradromics trial was implanted with the Connexus B.C.I. system, containing over 400 electrodes, in June at University of Michigan Health.”
Analyzed on 2026-09-19T04:40:17+00:00 · Last updated 2026-09-19
Plain language: Insufficient evidence was found to render a verdict.
Credibility score
out of 100
Based on 1 source
Low confidence
Original context
Show passage from source article
The woman, the first patient in the Paradromics clinical trial, was implanted with the company’s Connexus B.C.I. system, which contains more than 400 electrodes, in June at University of Michigan Health.
Extracted from: ‘I Have a Lot to Say’: Brain Implant Helps a Disabled Patient Speak , The New York Times
Evidence
This analysis is based on a single source. Confidence is low.
Bias distribution of supporting sources
Mean bias -0.20
Community Takes
No Takes have been written on this claim yet. Sign in to write a Take.